- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Charge for SRI case sinks ATL's results
It would have been a great quarter for ultrasound vendor AdvancedTechnology Laboratories. The Bothell, WA, company last week reportedthat revenues climbed 8% for the second quarter, while incometripled over the same period a year ago. Unfortunately,
It would have been a great quarter for ultrasound vendor AdvancedTechnology Laboratories. The Bothell, WA, company last week reportedthat revenues climbed 8% for the second quarter, while incometripled over the same period a year ago.
Unfortunately, ATL was forced to take a whopping $29.6 millionone-time charge in the quarter to pay for a damage award grantedto SRI International in connection with a patent infringementcase the company filed against ATL. A U.S. District Court judgein May assessed ATL $27.9 million in damages in connection withthe case (SCAN 6/5/96). ATL is pursuing an appeal of the decision.
The litigation charge wiped out what would have been a netprofit of $3.5 million. Instead, ATL wound up with a net lossfor the period of $19.2 million, compared with net income of $836,000in the second quarter of last year, when ATL took a one-time chargerelated to its consolidation of Interspec. ATL recorded an incometax benefit for the most recent quarter of $6 million.
ATL's revenues were a bright spot for the company, climbingto $98.6 million, compared with $91.3 million in the same periodof 1995. The company's gross margin improved to 48.4% from 46.6%due to an improved product mix and cost reduction programs.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
